Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2020 Oct 3;S1569-1993(20)30870-5. doi: 10.1016/j.jcf.2020.09.011. Online ahead of print.
Document
Link
Keywords
CFTR modulators [3]
Secondhand smoke [4]
Smoke exposure [5]
Tobacco [7]
Date
Saturday, October 3, 2020
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [8]